Join the 'Insomnia' group to help and get support from people like you.

Insomnia Blog

Related terms: Difficulty sleeping, Dyssomnia, Inability to sleep, Sleeplessness, Wakefulness

Start Sleep Drug Lunesta at Lower Dose for Safety, FDA Says

Posted 16 May 2014 by

THURSDAY, May 15, 2014 – Some users of the popular sleep medicine Lunesta remain too drowsy for safety during the day, and the recommended starting dose for the medicine should be lowered, the U.S. Food and Drug Administration said on Thursday. In a statement, the agency said it took the action due to studies showing that levels of Lunesta (eszopiclone) in some patients may remain high enough in the morning to interfere with driving and other activities that require them to be mentally alert. This impairment can occur even if patients feel fully awake, the FDA said. "To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia," Dr. Ellis Unger, director of the Office of Drug Evaluation I in the FDA's Center for Drug Evaluation and Research, said in the FDA news release. ... Read more

Related support groups: Insomnia, Lunesta

FDA Medwatch Alert: Eszopiclone Containing Sleep Aids: Drug Safety Communication - Can Cause Next-Day Impairment

Posted 15 May 2014 by

Including Lunesta and generics [Posted 05/15/2014] ISSUE: FDA has notified health professionals and their medical care organizations of a new warning that the insomnia drug Lunesta (eszopiclone) can cause next-day impairment of driving and other activities that require alertness. FDA recommends a decreased starting dose of Lunesta to 1 mg at bedtime. Women and men are equally susceptible to impairment from Lunesta, so the recommended starting dose of 1 mg is the same for both. FDA approved changes to the Lunesta prescribing information and the patient Medication Guide to include these new recommendations. The drug labels for generic eszopiclone products will also be updated to include these changes.   BACKGROUND: A study of Lunesta found that the previously recommended dose of 3 mg can cause impairment to driving skills, memory, and coordination that can last more than 11 hours after ... Read more

Related support groups: Insomnia, Lunesta, Eszopiclone

Insomnia May Raise Stroke Risk, Especially for Younger Adults

Posted 3 Apr 2014 by

THURSDAY, April 3, 2014 – People plagued with insomnia might have an increased risk of stroke, particularly if they are young adults, a new, large study from Taiwan suggests. Over the course of four years, researchers found that insomnia seemed to raise the likelihood that a person will be hospitalized due to stroke by 54 percent. That risk skyrocketed for people between the ages of 18 and 34, who were eight times more likely to suffer strokes if they had insomnia when compared to their peers who got good sleep, the study found. "We pay a lot of attention to high blood pressure, to obesity, to issues related to cholesterol. Those are known risk factors," said Dr. Demetrius Lopes, director of the Interventional Cerebrovascular Center at Rush University in Chicago and a spokesman for the American Heart Association. "But I think what is underrated is if you don't have a good sleep ... Read more

Related support groups: Insomnia, Ischemic Stroke

Insomniacs' Brains May Work Differently

Posted 28 Feb 2014 by

FRIDAY, Feb. 28, 2014 – The brains of insomniacs buzz with more activity during the day, preliminary new research suggests, offering possible insight into why people with sleep problems complain that their minds won't shut down at night. The findings, based on a small study of 28 people aged 50 and older, aren't definitive and won't immediately lead to help for insomniacs. But the results are "potentially getting us closer to different types of treatment to treat this excitability they're having in the brain," said study lead author Dr. Rachel Salas, a neurologist and assistant professor at the Johns Hopkins Medical Institution, in Baltimore. At issue: The millions of people who suffer from insomnia. About 10 percent to 15 percent of adults in the United States think they have chronic insomnia, according to the U.S. National Institutes of Health, while surveys by the National Sleep ... Read more

Related support groups: Insomnia

Insomnia Cure Boosts Success of Depression Treatment, Study Finds

Posted 19 Nov 2013 by

TUESDAY, Nov. 19, 2013 – Treating persistent insomnia at the same time as depression could double the chances that the mood disorder will disappear, a new study shows. Doctors have long reported a link between insomnia – the inability to sleep – and depression, but many thought that depression led to insomnia. Now, experts suspect sleep problems can sometimes precede depression. If other ongoing studies confirm these results, it might lead to major changes in depression treatment, experts added. Such changes would represent the biggest advance in depression treatment since the antidepressant Prozac was introduced in 1987, The New York Times reported. "The way this story is unfolding, I think we need to start augmenting standard depression treatment with therapy focused on insomnia," Colleen Carney, lead author of the small study, told the Times. The study was funded by the U.S. ... Read more

Related support groups: Depression, Insomnia

With Insomnia, Mind May Also Wander During Day

Posted 6 Sep 2013 by

THURSDAY, Sept. 5 – People with insomnia have trouble concentrating during the day because the "wandering mind" areas of their brains may not be turned off, according to a new study. Using brain imaging technology, researchers found that people with insomnia who were performing a working memory task did not rely less on the "default mode" regions of their brain that are usually active only when the mind is wandering. The findings might help explain why insomniacs do not function as efficiently during the day, and could also lead to improved treatments for the sleep disorder, according to the authors of the study published in the September issue of the journal Sleep. "We found that insomnia subjects did not properly turn on brain regions critical to a working memory task and did not turn off 'mind-wandering' brain regions irrelevant to the task," study lead author Sean Drummond said in ... Read more

Related support groups: Insomnia

Prescription Sleep Aids a Common Choice for American Insomnia

Posted 29 Aug 2013 by

THURSDAY, Aug. 29 – About 4 percent of American adults – more than 8.5 million people – have used a prescription sleep aid in the past month, and the use increases with age, U.S. health officials reported Thursday. In addition, more women (5 percent) than men (3.1 percent) over the age of 20 take these drugs, and those with higher education levels are more likely to use them, the researchers from the U.S. Centers for Disease Control and Prevention found. "This is the first time we have a national estimate on how many people are taking prescription medications for sleep," said report coauthor Yinong Chong, an epidemiologist at the CDC's National Center for Health Statistics. In the past 20 years, there has been reports of an increased number of prescriptions for sleep aids in the United States. But, Chong said, the use of such drugs has remained stable in the past decade, rising about ... Read more

Related support groups: Insomnia, Ambien, Zolpidem, Temazepam, Lunesta, Restoril, Ambien CR, Halcion, Triazolam, Sonata, Rozerem, Dalmane, Eszopiclone, Zaleplon, Flurazepam, Chloral Hydrate, Edluar, Estazolam, Somnote, Intermezzo

FDA Medwatch Alert: Tranquility by Health and Beyond, LLC: Recall - Undeclared Drug Ingredient

Posted 7 Aug 2013 by

ISSUE: Health and Beyond LLC is voluntarily recalling quantity lots of product Tranquility. The products have been found to contain a trace of Doxepin which is a pharmaceutical for sleep and Chlorpormazine for psychotic disorders. The product potentially could result in dizziness and cause public health risk. Health and Beyond LLC has not received any reports of adverse events related to this recall. BACKGROUND: The product is used as a sleep product and is packaged in a white bottle with 30 pills per bottle with lot #36678 and 36680. The affected product in the Tranquility lots include the expiration date 9/15. The product was distributed Nationwide, wholesale, retail and via internet. RECOMMENDATION: Health and Beyond LLC is notifying its distributors and customers by personal phone call and written recall letter and is arranging for return/replacement etc. of all recalled products. ... Read more

Related support groups: Insomnia

Could a Full Moon Keep You Up at Night?

Posted 25 Jul 2013 by

THURSDAY, July 25 – Many myths have told of the powers of a full moon, from werewolves to sudden madness to unexplained seizures, but new research suggests an impact close to home: Sound sleep may be harder to come by when the moon is in its full glory. The study suggests that the human body is cued not only to the daily rising and setting of the sun, which regulates circadian rhythms, but also to the phases of the moon. Published in the July 25 online issue of the journal Current Biology, the idea behind the finding was dreamed up in a bar one night as the Swiss researchers were having a drink. "A lot of people complain that they have bad sleep around a full moon. These are anecdotes, but you hear it from a lot of different people," said Silvia Frey, a neurobiologist at the University of Basel. "So, we were sitting there on a full moon night and just discussing this, and we thought ... Read more

Related support groups: Insomnia

Sleep Duration Linked to Suicidal Thoughts in People With Insomnia

Posted 27 May 2013 by

FRIDAY, May 24 – New research suggests a link between sleep duration and suicidal thoughts among people with insomnia. Every additional hour someone with insomnia sleeps is associated with a 72 percent drop in the likelihood of moderate or high risk of suicide, according to researchers from the University of Pennsylvania. "We were surprised by the strength of the association between sleep duration and suicide risk," study author, Linden Oliver, clinical research coordinator for the university's behavioral sleep medicine research program, said in a news release from the American Academy of Sleep Medicine. "A 72 percent decrease in the likelihood of moderate or high suicide risk with a one-hour increase in sleep is interesting given the small sample size." The study is scheduled for presentation June 4 at the annual meeting of the Associated Professional Sleep Societies in Baltimore. ... Read more

Related support groups: Insomnia

FDA: Lower Ambien's Dose to Prevent Drowsy Driving

Posted 15 May 2013 by

WEDNESDAY, May 15 – The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard while performing certain tasks such as driving. The move follows the FDA's request to manufacturers in January that drugs containing zolpidem carry instructions that lower the recommended dose and provide more safety information to patients. "FDA has approved these changes because of the known risk of next-morning impairment with these drugs," the agency said in a statement released Tuesday on its website. Sleep medications containing zolpidem include Ambien, Ambien CR, Edluar and Zolpimist, as well as generic versions of Ambien and Ambien CR. "The purpose of the lowering is to help decrease the risk of next-morning impairment of activities that require alertness," Dr. Ellis ... Read more

Related support groups: Sleep Disorders, Insomnia, Ambien, Zolpidem, Ambien CR, Edluar, Intermezzo, Zolpimist

FDA Medwatch Alert: Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Posted 14 May 2013 by

Including Ambien, Ambien CR, Edluar, and Zolpimist  [UPDATE 05/14/2013] Today, the U.S. Food and Drug Administration (FDA) is notifying the public that FDA has approved label changes specifying new dosing recommendations for zolpidem products (Ambien, Ambien CR, and Edluar), which are widely prescribed sleep medications. FDA has approved these changes because of the known risk of next-morning impairment with these drugs. [Posted 01/10/2013] ISSUE: FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving. This announcement focuses on zolpidem products approved for bedtime use, which are marketed as generics and under the brand names Ambien, ... Read more

Related support groups: Insomnia, Ambien, Zolpidem, Ambien CR, Intermezzo, Edluar, Zolpimist

Insomnia Hints at Future Hospitalization

Posted 10 May 2013 by

FRIDAY, May 10 – If you have trouble sleeping at night, you may be headed for more than just frustration and fatigue: Middle-aged and older adults with insomnia are more likely to be hospitalized and use home health care services, a new study suggests. Preventing insomnia in this group of people could reduce their use of health services by anywhere from 6 percent to 14 percent, according to the researchers from Johns Hopkins Bloomberg School of Public Health. The researchers looked at U.S. national data on insomnia symptoms and health-services use among nearly 14,400 middle-aged and older adults. They found that more than 40 percent of the study participants reported at least one insomnia symptom, such as trouble falling asleep, waking up during the night, and waking up too early and not being able to fall asleep again. The researchers said they found a significant association between ... Read more

Related support groups: Insomnia

ER Visits Tied to Ambien on the Rise

Posted 1 May 2013 by

WEDNESDAY, May 1 – There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study. Adverse reactions to zolpidem – the active ingredient in the sleep aids Ambien, Ambien CR, Edluar and Zolpimist – rose almost 220 percent between 2005 and 2010, researchers from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) found. The study authors concluded that use of these drugs for the short-term treatment of insomnia should be carefully monitored. Zolpidem, which has been approved by the U.S. Food and Drug Administration, has been used safely and effectively by millions of Americans, but adverse reactions to the medication have increased. Most of these cases involved people aged 45 and older, the researchers said. "Although short-term sleeping medications can help patients, it is ... Read more

Related support groups: Sleep Disorders, Insomnia, Ambien, Zolpidem, Ambien CR, Substance Abuse, Intermezzo, Edluar, Zolpimist

Health Tip: What's Keeping Your Child Awake?

Posted 15 Apr 2013 by

-- Insomnia is often thought of as an adult problem. But children, too, can have sleepless nights. The Nemours Foundation offers these potential causes for childhood insomnia: Being afraid of the dark. Having nightmares or bad dreams. Feeling stressed out or anxious about school or home life. Going through a major change in life, such as parents getting a divorce, moving, an illness or a death in the family. Being uncomfortable in some way, such as being too hot or too cold, hungry or too crowded in bed. Read more

Related support groups: Insomnia

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Nightmares, Night Terrors, Insomnia - Stimulant-Associated, Sleep Disorders

Related Drug Support Groups

gabapentin, Ambien, trazodone, clonazepam, Ativan, amitriptyline, lorazepam, mirtazapine, Elavil, view more... Zyprexa, zolpidem, melatonin, temazepam, diphenhydramine, quetiapine, Lunesta, doxepin, Tylenol PM, Restoril, phenobarbital, olanzapine, Ambien CR, oxazepam, 5-HTP, Unisom, tryptophan, valerian, Halcion, doxylamine, Advil PM, triazolam, Silenor, Sonata, Rozerem, Endep, Zyprexa Zydis, Dalmane, dimenhydrinate, Simply Sleep, zaleplon, eszopiclone, 5-hydroxytryptophan, flurazepam, Seconal, chloral hydrate, Sominex, Nytol, secobarbital, Excedrin PM, Edluar, Prosom, Somnote, estazolam, Intermezzo, Sleepinal, Nightime Sleepaid, lavender, Headache Relief PM, Bio-Melatonin, Midol PM, Percogesic Extra Strength, quazepam, pentobarbital, Seconal Sodium, Sleep Tabs, butabarbital, Doral, Motrin PM, Health Aid Melatonin, VesPro Melatonin, SGard, Zolpimist, Sleep Aid Tablets, Aldex AN, Melatonin Time Release, Doans PM, Aceta-Gesic, Seconal Sodium Pulvules, Ibuprofen PM, Acetadryl, Aldex AN Chewable, Doxytex, Sleep Tab II, aspirin/diphenhydramine, amobarbital, Vanatrip, 40 Winks, Medi-Sleep, Aquachloral Supprettes, ramelteon, diphenhydramine/magnesium salicylate, diphenhydramine/ibuprofen, Sleep-Eze-3, Somnicaps, Unisom with Pain Relief, Genapap PM, Mapap PM, acetaminophen/diphenhydramine, Nytol Maximum Strength, Twilite, Sleep-ettes, Nytol Caplet, Unisom SleepGels, Legatrin PM